Quest for a Cure

Help us chase our cure at this year’s

virtual Quest for a Cure Benefit

Thursday, November 12, 2020


The Castleman Disease Collaborative Network (CDCN) invites you to the 6th annual Quest for a Cure Benefit! This years virtual benefit has the potential to join together our largest group of patients, loved ones, and community members to raise awareness and funds for life-saving Castleman disease research. The
CDCN’s co-founder, Dr. David Fajgenbaum, physician-scientist at the University of Pennsylvania and author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action, is this year’s keynote speaker. To purchase tickets and become a sponsor click here

Event Details

  • Quest for a Cure will be held virtually this year
  • Thursday, November 12, 2020, 8pm EST
  • Interested in being a part of the event committee: Email us
  • More Details to follow!

Sponsorships & Tickets

All sponsorships will be recognized on our website for one year.

The CDCN is a 501 (c) (3) nonprofit organization. All donations are tax deductible in accordance with IRS regulations.

Crusader Sponsor $25,000

  • Recognition in all materials publicizing the event
  • Purchase your sponsorship here.

Castleman Sponsor $10,000

  • Recognition in all materials publicizing the event
  • Purchase your sponsorship here.

King Sponsor $5,000

  • Recognition in all materials publicizing the event
  • Purchase your sponsorship here.

Knight Sponsor $2,500

  • Recognition in all materials publicizing the event
  • Purchase your sponsorship here.

Bishop Sponsor $1,250

  • Recognition in all materials publicizing the event
  • Purchase your sponsorship here.

Noble Sponsor $500

  • Recognition on event signage
  • Purchase your sponsorship here.

Warrior Individual Registration

Thank you to all our sponsors who helped make our 2019 Quest for a Cure our best year yet! We could not have done this without you! 

About the CDCN

The CDCN’s innovative approach to transform Castleman disease research over the last seven years has resulted in the first diagnostic criteria for Castleman disease, first treatment guidelines, first new drug target in 25 years, and first clinical trial for patients with treatment-refractory Castleman disease. This work has been profiled on Good Morning America, New York Times, CNN, Philadelphia InquirerNPR Fresh Air, and the Lifetime TV NetworkThe CDCN has also partnered with the Chan Zuckerberg Initiative to expand the CDCN’s approach to research to advance cures for other rare diseases. 

More Information

  • Prefer to send a check by mail? Make out to: “CDCN” (Castleman Disease Collaborative Network), notate ‘Quest for A Cure,’ and send to: Castleman Disease Collaborative Network, PO Box 3614 Paso Robles, CA 93447
  • Questions? Email quest@castlemannetwork.org or call (610) 304-0696
  • CDCN is a 501 (c) (3) nonprofit organization. All donations are tax deductible in accordance with IRS regulations.

 

 

Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left